Endonovo Therapeutics Inc (OTC: ENDV) is a therapeutics company whose core business activity cannot be described with specificity from the available 10-K filing excerpts filed April 17, 2023 (accession 000149315223012553). The filing excerpts provided consist primarily of SEC cover page boilerplate, forward-looking statement disclaimers, and a description of a 2012 reverse acquisition in which IPR shareholders exchanged 33,234,294 shares for Company common shares, with IPR serving as the accounting acquirer. No product descriptions, revenue figures, segment disclosures, customer information, or operational business narrative are present in the supplied excerpts. A complete business description requires access to the full operative sections of the 10-K, including the Business and Management Discussion sections, which are not present in the provided source material.

Source: SEC 10-K, filed 2023-04-17

Industry: Electromedical & Electrotherapeutic Apparatus Peers: GlobeStar Therapeutics Corp GridAI Technologies Corp GENETHERA INC GENOCEA BIOSCIENCES, INC. Innoveren Scientific, Inc. Q BioMed Inc. PREMIER BIOMEDICAL INC